Government Contract Award GS35F502AA-15DDHQ18F00001335

Keegan filed this request with the Drug Enforcement Administration of the United States of America.
Tracking #

20-00317-F

Status
Completed

Communications

From: Keegan


To Whom It May Concern:

Pursuant to the Freedom of Information Act, I hereby request the following records:

Contract Number: GS35F502AA-15DDHQ18F00001335

Federal Contract Vehicle: Information Technology Schedule 70 (IT-70)

Dollars Obligated: 143075

Funding Agency: Drug Enforcement Administration (DOJ)

Awarding Agency: Drug Enforcement Administration (DOJ)

Awarded Vendor: Actionable Intelligence Technologies, Inc.

Award Date: 2018-09-12T00:00:00-04:00

NAICS Category: 511210 - Software Publishers

PSC Category: D319 - It And Telecom- Annual Software Maintenance Service Plans

Description: THIS IS FOR THE ANNUAL RENEWAL OF 10 AIT CFIS LICENSES. POP: 09/30/2018 TO 09/29/2019 GSA # GS-35F-502AA DUNS: 109448030 EIN: 33-0819188

Place of Performance: West Springfield, VA 22152, USA

Place of Performance State: Virginia

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

Keegan

From: Drug Enforcement Administration

Good Afternoon,

Attached, please find the acknowledgement letter for your recently submitted Freedom of Information/Privacy Act request. If you have any questions regarding your request, please contact our Customer Service Hotline on 202-307-7596. Thank you.

V/R
Josh Delo
Government Information Specialist
Freedom of Information & Privacy Act Unit (FSRF)
HQ Drug Enforcement Administration (DEA)

From: Drug Enforcement Administration

Good morning Mr. DeBence,

We have received the status update you requested. We regret the necessity of this delay, but please be assured that your request will be processed as soon as possible.

Thank you for your patience.

Kindly,
Glenda Lebby
IBSS Paralegal II (Contractor)
Freedom of Information/Privacy Act Unit (FSRF)
U.S. Department of Justice
Drug Enforcement Administration (DEA)
Glenda.J.Lebby@usdoj.gov<mailto:Glenda.J.Lebby@usdoj.gov>

From: Drug Enforcement Administration

Good afternoon.

Attached is the Covid-19 Signed Status Letter regarding your FOIA case number 20-00317-F.

If you have any additional question or concerns, please do not hesitate to reach out.

Thank you for your time and consideration,

Alicia Adams
IBSS Paralegal II (Contractor)

Freedom of Information/Privacy Act Unit (FSRF)

Drug Enforcement Administration (DEA)

Email: alicia.a.adams@usdoj.gov

PRIVACY ACT INFORMATION: This e-mail may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). If the reader of this communication is not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is strictly prohibited. If this communication has been received in error, please immediately delete all copies and notify me by e-mail.

From: Drug Enforcement Administration

Good Morning,

Thank you for your email regarding FOIA Request 20-00317-F. In regards to your most recent status inquiry, the documents pertaining to your FOIA Request 20-00317-F are currently under review by my supervisors. I do not have a time table for completion at this time.

If you have any additional question or concerns, please do not hesitate to reach out or contact our Customer Service Hotline on 202-307-7596.

Thank you for your time and consideration,

Alicia Adams
IBSS Paralegal II (Contractor)

Freedom of Information/Privacy Act Unit (FSRF)

Drug Enforcement Administration (DEA)

Email: alicia.a.adams@usdoj.gov

PRIVACY ACT INFORMATION: This e-mail may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). If the reader of this communication is not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is strictly prohibited. If this communication has been received in error, please immediately delete all copies and notify me by e-mail.

From: Drug Enforcement Administration

To Whom this may concern:

This case has been reassigned to me. This is in response to your latest status inquiry concerning your Freedom of Information Act/Privacy Act request dated March 30, 2020.

Please be advised, due to the national emergency concerning the novel coronavirus disease (COVID-19) outbreak, DEA, like many Federal Agencies, has mandated telework for its FOIA staff. As a result, DEA has limited access to certain cases, including yours. DEA will finish processing your request as quickly as possible at the resolution of the COVID-19 emergency.

We regret the necessity of this delay, but please be assured that your request is being handled as expeditiously as possible. Upon completion of the processing of your request, our office will notify you at the earliest possible date.

Thank you for your patience.

Kindly,
Glenda J. Lebby
IBSS Paralegal II (Contractor)
Freedom of Information/Privacy Act Unit
Processing Unit (FSRP)
U.S. Department of Justice/DEA/HQ
Glenda.J.Lebby@usdoj.gov<mailto:Glenda.J.Lebby@usdoj.gov>

From: Drug Enforcement Administration

To Whom this may concern:

This is in response to your latest status inquiry concerning your Freedom of Information Act/Privacy Act request dated March 30, 2020. We are in receipt of your recent inquiry regarding the status of your pending Freedom of Information/Privacy Act request.

Please be advised, our office is currently in the process of reviewing documents related to your request. Please be assured that your request is being handled as expeditiously as possible. Upon completion of our review, we will notify you at the earliest possible date. Your patience in this matter is appreciated.

Kindly,
Glenda J. Lebby
IBSS Paralegal II (Contractor)
Freedom of Information/Privacy Act Unit
(FSRP) Processing Unit
U.S. Department of Justice/DEA/HQ
Glenda.J.Lebby@usdoj.gov<mailto:Glenda.J.Lebby@usdoj.gov>

From: Drug Enforcement Administration

To Whom this may concern:

This is in response to your latest status inquiry concerning your Freedom of Information Act/Privacy Act request dated March 30, 2020. We are in receipt of your recent inquiry regarding the status of your pending Freedom of Information/Privacy Act request.

Please be advised, our office is currently in the process of reviewing documents related to your request. Please be assured that your request is being handled as expeditiously as possible. Upon completion of our review, we will notify you at the earliest possible date. Your patience in this matter is appreciated.

Kindly,
Glenda J. Lebby
IBSS Paralegal II (Contractor)
Freedom of Information/Privacy Act
(FSRP) Processing Unit
U.S. Department of Justice/DEA/HQ
Glenda.J.Lebby@usdoj.gov<mailto:Glenda.J.Lebby@usdoj.gov>

From: Drug Enforcement Administration

To Whom this may concern:

This is in response to your latest status inquiry concerning your Freedom of Information Act/Privacy Act request dated March 30, 2020. We are in receipt of your recent inquiry regarding the status of your pending Freedom of Information/Privacy Act request.

Please be advised, our office is currently in the process of reviewing documents related to your request. Please be assured that your request is being handled as expeditiously as possible. Upon completion of our review, we will notify you at the earliest possible date. Your patience in this matter is appreciated.
Kindly,
Glenda J. Lebby
IBSS Paralegal II (Contractor)
Freedom of Information/Privacy Act
(FSRP) Processing Unit
U.S. Department of Justice/DEA/HQ
Glenda.J.Lebby@usdoj.gov<mailto:Glenda.J.Lebby@usdoj.gov>

From: Drug Enforcement Administration

To Whom this may concern:
This is in response to your latest status inquiry concerning your Freedom of Information Act/Privacy Act request dated March 30, 2020. We are in receipt of your recent inquiry regarding the status of your pending Freedom of Information/Privacy Act request.
Please be advised, our office is currently in the process of reviewing documents related to your request. Please be assured that your request is being handled as expeditiously as possible. Upon completion of our review, we will notify you at the earliest possible date. Your patience in this matter is appreciated.

Kindly,
Glenda J. Lebby
IBSS Paralegal II (Contractor)
Freedom of Information/Privacy Act
(FSRP) Processing Unit
U.S. Department of Justice/DEA/HQ
Glenda.J.Lebby@usdoj.gov<mailto:Glenda.J.Lebby@usdoj.gov>

From: Drug Enforcement Administration

To Whom this may concern:
This is in response to your latest status inquiry concerning your Freedom of Information Act/Privacy Act request dated March 30, 2020. We are in receipt of your recent inquiry regarding the status of your pending Freedom of Information/Privacy Act request.
Please be advised, our office is currently in the process of reviewing documents related to your request. Please be assured that your request is being handled as expeditiously as possible. Upon completion of our review, we will notify you at the earliest possible date. Your patience in this matter is appreciated.

Kindly,
Glenda J. Lebby
IBSS Paralegal II (Contractor)
Freedom of Information/Privacy Act
(FSRP) Processing Unit
U.S. Department of Justice/DEA/HQ
Glenda.J.Lebby@usdoj.gov<mailto:Glenda.J.Lebby@usdoj.gov>

From: Drug Enforcement Administration

To Whom this may concern:

This is in response to your latest status inquiry concerning your Freedom of Information Act/Privacy Act request dated March 30, 2020. We are in receipt of your recent inquiry regarding the status of your pending Freedom of Information/Privacy Act request.

Please be advised, our office is currently in the process of reviewing documents related to your request. Please be assured that your request is being handled as expeditiously as possible. Upon completion of our review, we will notify you at the earliest possible date. Your patience in this matter is appreciated.
Kindly,
Glenda J. Lebby
IBSS Paralegal II (Contractor)
Freedom of Information Act/Privacy Act
(FSRP) Processing Unit
U.S. Department of Justice/DEA/HQ
Glenda.J.Lebby@usdoj.gov<mailto:Glenda.J.Lebby@usdoj.gov>

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients in not authorized and may be unlawful.

From: Drug Enforcement Administration

To Whom this may concern:
This is in response to your latest status inquiry concerning your Freedom of Information Act/Privacy Act request dated March 30, 2020. We are in receipt of your recent inquiry regarding the status of your pending Freedom of Information/Privacy Act request.
Please be advised, our office is currently in the process of reviewing documents related to your request. Please be assured that your request is being handled as expeditiously as possible. Upon completion of our review, we will notify you at the earliest possible date. Your patience in this matter is appreciated.

Kindly,
Glenda J. Lebby
IBSS Paralegal II (Contractor)
Freedom of Information Act/Privacy Act
(FSRP) Processing Unit
U.S. Department of Justice/DEA/HQ
Glenda.J.Lebby@usdoj.gov<mailto:Glenda.J.Lebby@usdoj.gov>

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients in not authorized and may be unlawful.

From: Drug Enforcement Administration

Good morning,

Please see the status letter attached. Thank you.

Kindly,
Glenda J. Lebby
IBSS Paralegal (Contractor)
Freedom of Information Act/Privacy Act
(FSRP) Processing Unit
U.S. Department of Justice/DEA/HQ
Glenda.J.Lebby@usdoj.gov<mailto:Glenda.J.Lebby@usdoj.gov>

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients in not authorized and may be unlawful.

From: Drug Enforcement Administration

Good morning,

Please see the attached response to your Freedom of Information Act/Privacy Act request Case Number 20-00317-F.

V/R
Josh Delo
Unit Chief
Processing Sub-Unit
Freedom of Information and Privacy Act Unit
FOIA and Information Law Section
Drug Enforcement Administration

NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients in not authorized and may be unlawful.

Files

pages

Close